Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study (DAIS)

American Journal of Cardiology

Volumn 84, Issue 9, 1999, Pages 1004-1010

  Steiner, George ^a   Stewart, Dawn ^b   Hosking, James Donald ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CHOLESTEROL; FENOFIBRATE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CANADA; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES CONTROL; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DYSLIPOPROTEINEMIA; EUROPE; FEMALE; GENDER; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTILIPEMIC AGENTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PROCETOFEN; RISK FACTORS;

EID: 0032701576     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00488-9     Document Type: Article

References (18)

1. Steiner G. Atherosclerosis, the major complication of diabetes. Vranic M., Hollenberg C.H., Steiner G. Comparison of Type I and Type II Diabetes Similarities and Dissimilarities in Etiology, Pathogenesis and Complications . 1985;277-297 Plenum Press, New York.
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:1998;229-234.
3. Miettinen H., Lehto S., Salomaa V., Mahonen M., Niemela M., Haffner S.M., Pyorala K., Tuomilehto J. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 21:1998;61-95.
4. Laakso M. Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus. Ann Med. 28:1996;341-345.
5. Assmann G., Schulte H. The Prospective Cardiovascular Munster (PROCAM) study prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease . Am Heart J. 116:1988;1713-1724.
6. Elkeles R.S., Diamond J.R., Poulter C., Dhanjil S., Nicolaides A.N., Mahmood S., Richmond W., Mather H., Sharp P., Feher M.D. Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study . Diabetes Care. 21:1998;641-648.
7. Pyorala K., Pedersen T.R., Kjekshus J., Faergeman O., Olsson A.G., Thorgeirsson G. Cholesterol lowering with simvastatin improves the prognosis of diabetic patients with coronary heart disease. Diabetes Care. 20:1997;614-620.
8. Goldberg R.B., Mellies M.J., Sacks F.M., Moye L.A., Howard B.V., Howard W.J., Davis B.R., Cole T.G., Pfeffer M.A., Braunwald E. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators . Circulation. 98:1998;2513-2519.
9. Steiner G. The Diabetes Atherosclerosis Intervention Study (DAIS) a study conducted in cooperation with the World Health Organization . Diabetologia. 39:1996;1655-1661.
10. McLaughlin P.R., Gladstone P. Diabetes Atherosclerosis Intervention Study (DAIS) quantitative coronary angiographic analysis of coronary artery atherosclerosis . Cathet Cardiovasc Diagn. 44:1998;249-256.
11. The Lipid Research Clinics Population Studies Data Book. Volume I. The Prevalence Study. U.S. Dept of Health and Human Services, Public Health Service, National Institutes of Health. NIH Publication No. 80-1527, 1980.
12. National Cholesterol Education Program, Second Report of the Expert Panel on Detection, Evaluation, and treatment of High Blood Cholesterol in Adults. National Institutes of Health, National Heart Lung and Blood Institute, NIH Publication No. 93-3095, 1993.
13. Stein Y. Comparison of European and USA guidelines for prevention of coronary heart disease. Atherosclerosis. 110:1994;S41-S44.
14. Steiner G. The dyslipoproteinemias of diabetes. Atherosclerosis. 110:1994;S27-S33.
15. U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care. 20:1997;1683-1687.
16. Giltay E.J., Elbers J.M., Gooren L.J., Emeis J.J., Kooistra T., Asscheman H., Stehouwer C.D. Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women modulation by cross-sex hormone administration . Arterioscl Thromb Vasc Biol. 18:1998;1716-1722.
17. Barrett-Connor E., Wingard D.L. Sex differential in ischemic heart disease mortality in diabetics A prospective population based study . Am J Epidemiol. 118:1983;489-496.
18. Watts G.F., Burke V. Lipid-lowering trials in the primary and secondary prevention of coronary heart disease new evidence, implications and outstanding issues . Curr Opin Lipidol. 7:1996;341-355.